Florida Surgeon General Joseph Ladapo accused the Biden administration of “actively preventing the effective distribution of monoclonal antibody treatments” in the United States, according to a Tuesday letter to Health and Human Services Minister Xavier Becerra.
The Biden administration recently halted shipments of COVID-19 antibody treatments manufactured by major drug companies Regeneron and Eli Lilly due to claims that such treatments are not effective against the omicron variant of coronavirus.
The federal government continues to supply Sotrovimab, a monoclonal antibody from the company Glaxosmithkline, which reportedly acts against omicron.
Ladapo ended his letter by referring to comments made by Biden on Monday that there was no solution from the federal government to end the nearly two-year-old pandemic.
“There is no federal solution. This is being resolved at the state level,” Biden said at the time in response to Arkansas Republican Gov. Asa Hutchinson warning the president against letting “federal solutions stand in the way of state solutions.”
The White House did not immediately respond to Fox News’ request for comment.
FLORDIA’S NEW SURGERY GENERAL: DATA DOES NOT SUPPORT MASK MANDATES IN SCHOOL
Ladapo, as DeSantis appointed in September after the former general surgeon resigned, has also created headlines for opposing measures such as school mask mandates.
In September, Florida Gov. Ron DeSantis hammered on Biden administration to revise the distribution of monoclonal antibodies in a way that would severely hamper the availability of treatment in several Republican-controlled states.
The Department of Health and Human Services alerted authorities in several southern red states – where the antibodies are widely used – after announcing that the agency would change how COVID-19 the treatment is distributed.
Fox News’ Tyler O’Neil and Houston Keene contributed to this report.